Speaker illustration

Mr Petri Niinisalo

University of Turku, Turku (Finland)

Petri is a solution-focused pharma & life science professional with over 10 years of research and over 9 years of commercial experience ranging from 2 person startup to a 50 000 employee multinational pharma company. Previously he has worked in various business intelligence and development assignments in e.g. Philips InnoHub, AstraZeneca, Orion Pharma and Sanofi Genzyme. Petri has extensive academic experience from being Innovation Manager at the University of Vaasa to Business Advisor position in Aalto Center for Entrepreneurship. In his academic positions, he had a major role in negotiating and creating joint projects with several business partners and raising over 1,1 M€ for projects. Currently Petri is advancing his Ph.D. in Drug Research Doctoral Programme at Medical School, University of Turku, and performing Business Expertise curriculum at Turku School of Economics. Petri is also one of the Business Mentors at Vertical Health Accelerator located in Helsinki, Finland.

IDO activity forecasts obesity in premenopausal females in 10-year follow-up study: the Cardiovascular Risk in Young Finns Study.

Event: ESC Congress 2019

Topic: Cardiovascular Disease in Women

Session: Women

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb